https://www.businesswire.com/news/home/20260207932893/en/Genentechs-Fenebrutinib-Is-the-First-Investigational-Medicine-in-Over-a-Decade-That-Reduces-Disability-Progression-in-Primary-Progressive-Multiple-Sclerosis-PPMS 2026-02-07T20:40:00.000Z weekly 0.5 Business Wire en PressRelease 2026-02-07T20:40:00.000Z Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS) RHHBY,ROG,RO https://mms.businesswire.com/media/20260207932893/en/2702039/21/GNE_Logo_Strapline_BLK_081525.jpg https://www.businesswire.com/news/home/20260207783207/en/HUBG-SHAREHOLDER-INVESTIGATION-NOTICE-Faruqi-Faruqi-LLP-Investigates-Claims-on-Behalf-of-Investors-of-Hub-Group 2026-02-07T17:06:00.000Z weekly 0.5 Business Wire en PressRelease 2026-02-07T17:06:00.000Z HUBG SHAREHOLDER INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hub Group HUBG https://mms.businesswire.com/media/20260207783207/en/2669297/21/FF_BW_Image_2.jpg https://www.businesswire.com/news/home/20260207972901/en/DCO-Concludes-5th-General-Assembly-with-Adoption-of-the-Kuwait-Declaration-on-Responsible-AI-for-Global-Digital-Prosperity 2026-02-07T15:41:00.000Z weekly 0.5 Business Wire en PressRelease 2026-02-07T15:41:00.000Z DCO Concludes 5th General Assembly with Adoption of the Kuwait Declaration on Responsible AI for Global Digital Prosperity https://mms.businesswire.com/media/20260207972901/en/2714368/21/DCO_concludes_5th_General_Assembly_%28Photo_AETOSWire%29.jpg https://www.businesswire.com/news/home/20260207459870/en/ITGR-Deadline-Rosen-Law-Firm-Urges-Integer-Holdings-Corporation-NYSE-ITGR-Stockholders-to-Contact-the-Firm-for-Information-About-Their-Rights 2026-02-07T14:00:00.000Z weekly 0.5 Business Wire en PressRelease 2026-02-07T14:00:00.000Z ITGR Deadline: Rosen Law Firm Urges Integer Holdings Corporation (NYSE: ITGR) Stockholders to Contact the Firm for Information About Their Rights ITGR https://mms.businesswire.com/media/20260207459870/en/1164042/21/July_30%2C_2021_-_ROSEN_LOGO.jpg https://www.businesswire.com/news/home/20260206004579/en/Wisely-Ai-Sets-a-New-Impact-Benchmark-Protecting-100-Mn-Indosat-Users-from-2-Bn-Scam-and-Spam-Communications-in-Indonesia 2026-02-07T08:45:00.000Z weekly 0.5 Business Wire en PressRelease 2026-02-07T08:45:00.000Z Wisely Ai Sets a New Impact Benchmark Protecting 100 Mn Indosat Users from 2 Bn+ Scam and Spam Communications in Indonesia TANLA https://mms.businesswire.com/media/20260206004579/en/2713577/21/tanlalogo.jpg https://www.businesswire.com/news/home/20260206468111/en/Honda-and-Mythic-Announce-Joint-Development-of-100x-Energy-Efficient-Analog-AI-Chip-for-Next-Generation-Vehicles 2026-02-07T05:40:00.000Z weekly 0.5 Business Wire en PressRelease 2026-02-07T05:40:00.000Z Honda and Mythic Announce Joint Development of 100x Energy-Efficient Analog AI Chip for Next-Generation Vehicles https://mms.businesswire.com/media/20260206468111/en/2713871/21/Mythic_Logo_BW.jpg https://www.businesswire.com/news/home/20260206901173/ja 2026-02-07T03:55:00.000Z weekly 0.5 Business Wire ja PressRelease 2026-02-07T03:55:00.000Z ラピッド・メディカル、DISTALS試験の極めてポジティブな結果で中型血管性脳卒中におけるTIGERTRIEVER™ 13の優れた再灌流効果を実証 https://mms.businesswire.com/media/20260206901173/ja/2713763/21/RapidMedical_EWP_logo.jpg https://www.businesswire.com/news/home/20260206126183/fr 2026-02-07T03:54:00.000Z weekly 0.5 Business Wire fr PressRelease 2026-02-07T03:54:00.000Z L’essai DISTALS de Rapid Medical™ est extrêmement positif, montrant une reperfusion supérieure avec TIGERTRIEVER™ 13 après un AVC des vaisseaux de moyen calibre https://mms.businesswire.com/media/20260206126183/fr/2713763/21/RapidMedical_EWP_logo.jpg https://www.businesswire.com/news/home/20260206750288/it 2026-02-07T03:54:00.000Z weekly 0.5 Business Wire it PressRelease 2026-02-07T03:54:00.000Z Riassunto: Il trial DISTALS di Rapid Medical™ riporta risultati straordinariamente positivi, dimostrando la superiorità di riperfusione di TIGERTRIEVER™ 13 nell’ictus dei medi vasi https://mms.businesswire.com/media/20260206750288/it/2713763/21/RapidMedical_EWP_logo.jpg https://www.businesswire.com/news/home/20260206097059/en/STKL-Stock-Alert-Halper-Sadeh-LLC-is-Investigating-Whether-SunOpta-Inc.-is-Obtaining-a-Fair-Price-for-its-Shareholders 2026-02-07T01:58:00.000Z weekly 0.5 Business Wire en PressRelease 2026-02-07T01:58:00.000Z STKL Stock Alert: Halper Sadeh LLC is Investigating Whether SunOpta Inc. is Obtaining a Fair Price for its Shareholders STKL https://mms.businesswire.com/media/20260206097059/en/1567526/21/Firm_Logo-with_Investor_Law_Firm.jpg https://www.businesswire.com/news/home/20260206121457/en/RR-INVESTOR-REMINDER-Richtech-Robotics-Inc.-Investors-Have-Until-April-3-2026-To-Seek-Lead-Plaintiff-Role-Contact-Kirby-McInerney-LLP 2026-02-07T01:00:00.000Z weekly 0.5 Business Wire en PressRelease 2026-02-07T01:00:00.000Z RR INVESTOR REMINDER: Richtech Robotics Inc. Investors Have Until April 3, 2026 To Seek Lead Plaintiff Role – Contact Kirby McInerney LLP RR https://mms.businesswire.com/media/20260206121457/en/774509/21/new_KM_logo.jpg https://www.businesswire.com/news/home/20260206485830/en/AI-Sales-Platform-ACTi-Launches-to-Solve-the-Sales-Hiring-Crisis-for-Businesses 2026-02-07T00:23:00.000Z weekly 0.5 Business Wire en PressRelease 2026-02-07T00:23:00.000Z AI Sales Platform ACTi Launches to Solve the Sales Hiring Crisis for Businesses https://mms.businesswire.com/media/20260206485830/en/2714087/21/Sean_1_-_v2.jpg https://www.businesswire.com/news/home/20260206232451/en/Richtech-Robotics-Inc.-Securities-Class-Action-Lawsuit-Filed-Lead-Plaintiff-Deadline-April-3-2026-Robbins-Geller-Rudman-Dowd-LLP 2026-02-07T00:20:00.000Z weekly 0.5 Business Wire en PressRelease 2026-02-07T00:20:00.000Z Richtech Robotics Inc. Securities Class Action Lawsuit Filed; Lead Plaintiff Deadline April 3, 2026 – Robbins Geller Rudman & Dowd LLP RR https://mms.businesswire.com/media/20260206232451/en/2313484/21/RGRD_Logo_2v2.jpg https://www.businesswire.com/news/home/20260206316924/zh-CN 2026-02-07T00:10:00.000Z weekly 0.5 Business Wire zh-CN PressRelease 2026-02-07T00:10:00.000Z Rapid Medical™的DISTALS试验结果极为积极，证实TIGERTRIEVER™ 13对治疗中血管卒中具有卓越的再灌注效果 https://mms.businesswire.com/media/20260206316924/zh-CN/2713763/21/RapidMedical_EWP_logo.jpg https://www.businesswire.com/news/home/20260206353931/de 2026-02-07T00:04:00.000Z weekly 0.5 Business Wire de PressRelease 2026-02-07T00:04:00.000Z Die DISTALS-Studie von Rapid Medical™ ist äußerst positiv und belegt eine überlegene Reperfusion mit TIGERTRIEVER™ 13 bei Schlaganfällen in mittleren Gefäßen https://mms.businesswire.com/media/20260206353931/de/2713763/21/RapidMedical_EWP_logo.jpg https://www.businesswire.com/news/home/20260206641117/en/Johnson-Johnson-Presents-Early-Outcomes-from-the-OMNY-AF-Pilot-Study-at-2026-AF-Symposium 2026-02-07T00:00:00.000Z weekly 0.5 Business Wire en PressRelease 2026-02-07T00:00:00.000Z Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium JNJ https://mms.businesswire.com/media/20260206641117/en/2713769/21/JJ_Logo_SingleLine_Red_RGB.jpg